 |
|
December 2011
|
CONGRESS REACHES FY2012 SPENDING COMPROMISE
In otherwise bleak budget year, NIH and NCI to receive increased funds
After months of debate and facing another possibility of a government shutdown, Congress reached a last-minute compromise on fiscal year 2012 spending priorities, including funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Read more
2011 IN REVIEW
A review of this year’s biggest stories for cancer research and their implications for 2012
Take a look back at the events that shaped 2011 and read predictions for what to expect in 2012. Read more
VARMUS UPDATES CANCER ADVISORY BOARD
Director anticipates contentious budget year in FY2013
While addressing the NCI National Cancer Advisory Board on Dec. 6, the institute’s director, Harold Varmus, M.D., told board members to brace for a contentious budget year in fiscal year 2013, but added that the institute has at hand the resources to do “some important things” to make continued progress against cancer. Read more
AACR CONVENES DISCUSSION ABOUT CANCER DRUG DEVELOPMENT
AACR Task Force to spearhead further opportunities to examine policy issues facing cancer researchers and regulators
During an AACR scientific conference last month, representatives from European and U.S. regulatory bodies joined scientists from academia and industry to discuss the challenges facing rational cancer drug development for targeted drugs. Read more
Top